Search Immortality Topics:

Page 420«..1020..419420421422..»

Category Archives: Stem Cell Therapy

OncoMed Has 'Wnt' in its Sails

OncoMed Has 'Wnt' in its Sails; Bayer Deal Adds $40M Up Front by Jennifer Boggs, Bioworld, June 18, 2010. Excerpts: [OncoMed's] latest accomplishment is another early stage deal, this time with Bayer Schering Pharma AG, to develop drugs targeting the … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on OncoMed Has 'Wnt' in its Sails

Patent application: Levels of Oct1 as a method of identifying CSCs

(WO2010065400) Cancer Biomarker and Methods of Using Thereof.Excerpt from PCT Biblio. Data: International Application No.: PCT/US2009/065742Publication Date: 10.06.2010Excerpt from Description: Described herein are biomarkers which can be used for identifying a subject at risk for or evaluating the progression of … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on Patent application: Levels of Oct1 as a method of identifying CSCs

New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

By BRADLEY J. FIKES - [email protected] | Posted: June 15, 2010 3:21 pm |OCEANSIDE ---- For the first time in years, International Stem Cell Corp. has cleared its balance sheet of debt and has enough cash to last for "another … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

By BRADLEY J. FIKES - [email protected] | Posted: June 15, 2010 3:21 pm |OCEANSIDE ---- For the first time in years, International Stem Cell Corp. has cleared its balance sheet of debt and has enough cash to last for "another … Continue reading

Posted in Stem Cell Therapy | Comments Off on New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

Decitabine may target ovarian CSCs?

Two-Drug Phase I Trial Shows Promise in Treating Late-Stage Ovarian Cancer, ScienceDaily, June 13, 2010. Excerpt: "Our hypothesis is that decitabine isn't just targeting active ovarian cancer cells, but also cancer stem cells that seem to survive the first treatments," … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on Decitabine may target ovarian CSCs?

International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’

International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’